96 related articles for article (PubMed ID: 8126454)
1. Capsid destabilization is required for antibody-mediated disruption of poliovirus.
Delaet I; Boeyé A
J Gen Virol; 1994 Mar; 75 ( Pt 3)():581-7. PubMed ID: 8126454
[TBL] [Abstract][Full Text] [Related]
2. Hit-and-run neutralization of poliovirus.
Brioen P; Rombaut B; Boeyé A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
[TBL] [Abstract][Full Text] [Related]
3. Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength.
Delaet I; Vrijsen R; Boeyé A
Virology; 1992 May; 188(1):93-101. PubMed ID: 1314469
[TBL] [Abstract][Full Text] [Related]
4. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
5. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
6. Disoxaril stabilization and immunogenicity of poliovirus procapsids.
Rombaut B; Brioen P; Boeyé A
J Gen Virol; 1990 May; 71 ( Pt 5)():1081-6. PubMed ID: 2161045
[TBL] [Abstract][Full Text] [Related]
7. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
8. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
Shyrobokov VP; Kostenko IH; Nikolaienko IV
Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
10. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
11. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
Rombaut B; Vrijsen R; Boeyé A
J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of VP1 and modification of antigenic site 1 of type 2 polioviruses by intestinal trypsin.
Roivainen M; Hovi T
J Virol; 1988 Sep; 62(9):3536-9. PubMed ID: 2841503
[TBL] [Abstract][Full Text] [Related]
13. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
[TBL] [Abstract][Full Text] [Related]
15. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.
Emini EA; Kao SY; Lewis AJ; Crainic R; Wimmer E
J Virol; 1983 May; 46(2):466-74. PubMed ID: 6188863
[TBL] [Abstract][Full Text] [Related]
16. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
17. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells.
Pfister T; Pasamontes L; Troxler M; Egger D; Bienz K
Virology; 1992 Jun; 188(2):676-84. PubMed ID: 1316678
[TBL] [Abstract][Full Text] [Related]
19. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating.
Wetz K
Virology; 1993 Feb; 192(2):465-72. PubMed ID: 8380661
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
Li Q; Yafal AG; Lee YM; Hogle J; Chow M
J Virol; 1994 Jun; 68(6):3965-70. PubMed ID: 7514682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]